A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3
Trial details
- Registry ID
- NCT05461105
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3NCT05461105 | Hepion Pharmaceuticals, Inc. | Phase 2 | Completed | 2023-04-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |